Skip to content

Intravenous iron

DRUG8 trials

Sponsors

Chulalongkorn University, Chiang Mai University, Hospital Universitari de Bellvitge, Leiden University Medical Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions

AnemiaESRD who receiving erythropoietin stimulating agent. Ret-He, ESRD, functional iron deficiency anemiaGynecologic CancerHemodialysis ComplicationInfective EndocarditisInflammatory Bowel DiseasesIron Deficiency AnemiaIron-deficiency

Phase 1

Phase 2

Phase 3

Phase 4

Unknown Phase

Related Papers